As CVS Health has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

The diversified healthcare company reports earnings next month.

If you are wondering whether CVS Health's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are saying about value right now. Over the ...

In the last year, multiple insiders have substantially increased their holdings of CVS Health Corporation stock, indicating that insiders' optimism about the company's prospects h ...

CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and ...

With CVS reestablishing forward guidance and offering a deeply discounted valuation, the balance of risk favors upside.

Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need ...

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

Most readers would already know that CVS Health's (NYSE:CVS) stock increased by 1.6% over the past month. However, ...